0001415889-24-002080.txt : 20240131 0001415889-24-002080.hdr.sgml : 20240131 20240131173057 ACCESSION NUMBER: 0001415889-24-002080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240129 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wainer Andrea F CENTRAL INDEX KEY: 0001778070 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 24584082 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-01312024_100152.xml X0508 4 2024-01-29 0000001800 ABBOTT LABORATORIES ABT 0001778070 Wainer Andrea F 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false EXECUTIVE VICE PRESIDENT 1 Common shares without par value 2024-01-29 4 M 0 25000 44.40 A 90027 D Common shares without par value 2024-01-29 4 S 0 25000 112.50 D 65027 D Common shares without par value 2024-01-29 4 M 0 17500 59.94 A 82527 D Common shares without par value 2024-01-29 4 S 0 17500 112.50 D 65027 D Option (right to buy) 44.40 2024-01-29 4 M 0 25000 0 D 2020-02-17 2027-02-16 Common Shares 25000 13271 D Option (right to buy) 59.94 2024-01-29 4 M 0 17500 0 D 2021-02-16 2028-02-15 Common Shares 17500 46949 D Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. /s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact 2024-01-31